Discover investment opportunities in Best Healthcare Stocks 2024 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Healthcare Stocks 2024 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Healthcare Stocks 2024 using our Smart AI Filter.
8 stocks found for "Best Healthcare Stocks 2024"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.36 | ±26.9% | 24.5 | 0.00% | |||
0.33 | ±27.9% | 8.6 | 4.00% | |||
0.59 | ±31.6% | 34.5 | 0.77% | |||
0.37 | ±19.7% | 14.7 | 3.18% | |||
0.32 | ±24.8% | 8.7 | 6.75% | |||
0.64 | ±28.2% | 69.3 | 0.00% | |||
0.77 | ±40.2% | 10.4 | 3.94% | |||
0.49 | ±19.6% | 26.1 | 1.76% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What makes Johnson & Johnson (JNJ) a stable investment in the healthcare sector?
A: Johnson & Johnson, as a multinational manufacturer in pharmaceuticals, medical devices, and consumer health products, benefits from diversified revenue streams. Historically, the company has shown resilience thanks to its ability to adapt to market fluctuations and its focus on R&D for sustainable future growth.
Q: How does Pfizer (PFE) position itself in terms of innovation and growth?
A: Pfizer is recognized for its innovation, especially its development of vaccines and therapies, contributing significantly to its growth. Investors often consider Pfizer's robust pipeline and strategic partnerships as key factors for potential future advances in pharmaceuticals.
Q: What are the dividend prospects for UnitedHealth Group (UNH) investors?
A: UnitedHealth Group has consistently demonstrated strong financial health, making it a potential candidate for stable dividend income. The company’s diverse range of services in health insurance and care delivery contributes to consistent cash flow.
Q: Why might AbbVie Inc. (ABBV) attract value-focused investors?
A: AbbVie is often appealing to value investors due to its strong pipeline of immunology and oncology products. Despite patent expirations affecting revenue, strategic M&A activities, like acquiring Allergan, may bolster future growth.
Q: What are the growth prospects for Eli Lilly and Company (LLY) in the pharmaceutical industry?
A: Eli Lilly focuses heavily on developing innovative therapies, including those for diabetes and cancer, which provides significant growth potential. Their commitment to R&D often positions the company favorably within the industry for future expansion.
Q: How does Merck & Co., Inc. (MRK) maintain competitive advantage in its market?
A: Merck sustains its competitive edge through a strong portfolio of vaccines and oncology drugs. Investments in innovation and global reach contribute to its robust market position and potential long-term growth.